Organization | Istanbul Medeniyet University

Istanbul Medeniyet University Report issue

Academic/Hospital Phase 4

Founded: Istanbul Turkey (2010)

Organization Overview

First Clinical Trial

2013

NCT02501564

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Alternative names

Istanbul Medeniyet University | Istanbul Medeniyet University Physical Medicine and Rehaiblitation Clinic | Medeniyet University | Physiotherapy and Rehabilitation, Faculty of Health Sciences, Istanbul Medeniyet University | Taha Uçar

Active Ingredients

Drugs in Phase 4 Trials (5)

alprazolam (xanax) (1 trial)

codeine (Phenergan) (1 trial)

diclofenac (voltaren) (1 trial)

hydroxyzine (vistaril) (1 trial)

naproxen (naprosyn) (1 trial)

Drugs in Other Trials (3)

allopurinol (zyloprim) (1 trial)

chlorhexidine (hibitane) (1 trial)

lactobacillus rhamnosus (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Hematuria (Phase 4)

Hyperplasia (Phase 4)

Lower Urinary Tract Symptoms (Phase 4)

Osteoarthritis (Phase 4)

Prostatic Hyperplasia (Phase 4)

Psychomotor Agitation (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 6
# of Trial APIs: 8